JPMorgan sees the shares of Bangkok Dusit-Aktie in an attractive view from Investing.com

A Donnerstag student JPMorgan is the Action of Bangkok Dusit Medical Services (BDMS:TB) (OTC: BDULF) of Neutral on Overweight high and high at the price of 31.00 THB to 33.00 THB. This new development has resulted in the Bangkok Dusit stock underperforming the Stock Exchange of Thailand (SET) index by 15% in the three months.

The treatment can lead to ideas that have a slower effect on higher risks of infection and versicherungsinfections that can lead to the prevention of previous infections during the extensive treatment.

Trotz dieser Marktbedenken said Bangkok Dusit in the young years Quarters a remarkable Ertragsstabilität. The profit forecasts for the external economies would, after correction, be supported by a comprehensive overall portfolio portfolio.

JPMorgan views the company’s active interests as attractive. With a turnover of a turnover in earnings before sentences, shares, depreciation and amortization (EV/EBITDA) on June 16 for the stock market in 2025 in Bangkok, so it is a comparison for others in the regional Healthcare sector.

The analysts who took into account Bangkok’s annual growth rate (CAGR) of EBITDA at an average of 8% were more attractive regionally.

There is a problem that the waiting room of Bangkok Dusit center Bumrungrad Hospital (BH) in naher Zukunft can expand the interest of the investors in Bangkok.

With JPMorgan aware of the overweight, the cash flow (DCF) was based on a December 2025 share price decline from THB 32 to THB 34.

This breakthrough will make a fortune from the bet as one of the gains for Action (EPS) by 4-6%, which is based on Bangkok’s strong quarters. The problem of the internal market, in which the market conditions are put on the market, is an inseparable factor for the automatic einschätzung.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.